Briefing
Determinants of Circulating Tumor HPV DNA in Surgically Treated Oropharyngeal Cancer.
A retrospective cohort examined which clinicopathologic features were associated with circulating tumor HPV DNA before and after upfront surgery for HPV-mediated oropharyngeal cancer.
- Design: Evidence level 3
- Assay: ctHPVDNA
JAMA Otolaryngology–Head & Neck SurgeryPubMed 41926134DOI 10.1001/jamaoto.2026.0015